{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:01:36Z","timestamp":1792544496112,"version":"4.5.0"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T00:00:00Z","timestamp":1137369600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T00:00:00Z","timestamp":1137369600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1111\/j.1365-2133.2005.07067.x","type":"journal-article","created":{"date-parts":[[2006,1,16]],"date-time":"2006-01-16T17:10:37Z","timestamp":1137431437000},"page":"726-729","source":"Crossref","is-referenced-by-count":129,"title":["Etanercept: effective in the management of hidradenitis suppurativa"],"prefix":"10.1093","volume":"154","author":[{"given":"C.","family":"Cusack","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Buckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,1,16]]},"reference":[{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"Von Der Werth","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1046\/j.1365-2230.2002.104311.x","article-title":"Management of hidradenitis suppurativa","volume":"27","author":"Mortimer","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1046\/j.1365-2230.2002.11125.x","article-title":"Methotrexate is of limited value in the treatment of hidradenitis suppurativa","volume":"27","author":"Jemec","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2133.1992.tb00693.x","article-title":"Successful treatment of hidradenitis suppurativa and retroauricular acne with etretinate","volume":"126","author":"Chow","year":"1992","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1067\/mjd.2002.124601","article-title":"Scanner-assisted carbon dioxide laser surgery: a retrospective follow-up study of patients with hidradenitis suppurativa","volume":"47","author":"Lapins","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/j.1365-2133.2003.05663.x","article-title":"Infliximab for hidradenitis suppurativa","volume":"149","author":"Sullivan","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB7|cit7","first-page":"735","volume-title":"Dermatological Surgery: Principles and Practice","author":"Hurley","year":"1989"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1046\/j.1365-2133.2000.03476.x","article-title":"The clinical genetics of hidradenitis suppurativa revisited","volume":"142","author":"Von Der Werth","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/120347540300700109","article-title":"Hidradenitis suppurativa","volume":"7","author":"Jemec","year":"2003","journal-title":"J Cutan Med Surg"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000018126","article-title":"Cigarette smoking as a triggering factor of hidradenitis suppurativa","volume":"198","author":"Konig","year":"1999","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1099\/00222615-48-1-103","article-title":"Aerobic and anaerobic microbiology of axillary hidradenitis suppurativa","volume":"48","author":"Brook","year":"1999","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00000637-198703000-00009","article-title":"Follicular occlusion triad: hidradenitis suppurativa, acne conglobata, and dissecting cellulitis of the scalp","volume":"18","author":"Chicarilli","year":"1987","journal-title":"Ann Plast Surg"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2133.1991.tb14178.x","article-title":"Hidradenitis suppurativa in Crohn's disease","volume":"125","author":"Ostlere","year":"1991","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00054725-200111000-00008","article-title":"Hidradenitis suppurativa and Crohn's disease: response to treatment with infliximab","volume":"7","author":"Martinez","year":"2001","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1111\/j.1572-0241.2002.05950.x","article-title":"Axillary hidradenitis suppurativa successfully treated with infliximab in a Crohn's disease patient","volume":"97","author":"Katsanos","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/S0149-2918(99)80015-0","article-title":"Infliximab: a novel chimeric monoclonal antibody for the treatment of Crohn's disease","volume":"21","author":"Mouser","year":"1999","journal-title":"Clin Ther"},{"issue":"Suppl. 3","key":"10.1111\/j.1365-2133.2005.07067.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaad.2003.10.063","article-title":"Clinical improvement of refractory hidradenitis suppurativa with etanercept. Poster 58","volume":"50","author":"Jurgensmayer","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00054725-199905000-00008","article-title":"Antitumor necrosis factor therapy for inflammatory bowel disease. a review of agents, pharmacology, clinical results, and safety","volume":"5","author":"Sandborn","year":"1999","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1517\/13543784.9.1.103","article-title":"Anti-TNF agents in Crohn's disease","volume":"9","author":"Van Assche","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/art.20311","article-title":"Lymphoma in rheumatoid arthritis. the effect of methotrexate and anti-tumor necrosis factor therapy in 18 572 patients","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2125.2001.00321.x","article-title":"Anti-TNF agents for rheumatoid arthritis","volume":"51","author":"Seymour","year":"2001","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB23|cit23","first-page":"893","article-title":"Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein","volume":"137","author":"Zeltser","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1034\/j.1600-0609.2003.00115.x","article-title":"Aplastic anemia following administration of a tumor necrosis factor-alpha inhibitor","volume":"71","author":"Kuruvilla","year":"2003","journal-title":"Eur J Haematol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1046\/j.1365-2230.2003.01411.x","article-title":"Etanercept-induced systemic lupus erythematosus","volume":"28","author":"Swale","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7326\/0003-4819-130-6-199903160-00004","article-title":"Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial","volume":"130","author":"Moreland","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1046\/j.1365-2133.2002.4653_4.x","article-title":"Dermatological complications of etanercept therapy for rheumatoid arthritis","volume":"146","author":"Misery","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W","article-title":"Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides","volume":"44","author":"Mohan","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB29|cit29","first-page":"S532","article-title":"Global safety and efficacy of more than 5 years of etanercept (Enbrel) therapy in rheumatoid arthritis","volume":"46","author":"Moreland","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2133.2005.07067.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1056\/NEJMoa030409","article-title":"Etanercept as monotherapy in patients with psoriasis","volume":"349","author":"Leonardi","year":"2003","journal-title":"N Engl J Med"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.07067.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2005.07067.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2005.07067.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T14:15:42Z","timestamp":1676384142000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/154\/4\/726\/6637209"}},"subtitle":["Etanercept: effective in the management of HS"],"short-title":[],"issued":{"date-parts":[[2006,1,16]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2005.07067.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1,16]]}}}